Tamarack Advisers, LP Vertex Pharmaceuticals Inc Transaction History

Tamarack Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $4.69 Million - $5.53 Million	-25,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $3.52 Million - $4.1 Million	-17,000 Reduced 40.48%	25,000 $5.37 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $8.69 Million - $11.6 Million	42,000 New	42,000 $9.59 Million

1,718

226M

1.21M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.